株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の美容医学市場規模、シェア、動向分析:製品別(エネルギーベースデバイス、皺防止製品)、エンドユース別(クリニック・ビューティセンター、在宅使用)、地域別、セグメント予測(2019~2026年)

Aesthetic Medicine Market Size, Share and Trends Analysis Report By Procedure Type (Invasive Procedures, Non-invasive Procedures), By Region (North America, Europe, APAC, MEA, LATAM), And Segment Forecasts, 2019 - 2026

発行 Grand View Research, Inc. 商品コード 906544
出版日 ページ情報 英文 130 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=110.09円で換算しております。
世界の美容医学市場規模、シェア、動向分析:製品別(エネルギーベースデバイス、皺防止製品)、エンドユース別(クリニック・ビューティセンター、在宅使用)、地域別、セグメント予測(2019~2026年) Aesthetic Medicine Market Size, Share and Trends Analysis Report By Procedure Type (Invasive Procedures, Non-invasive Procedures), By Region (North America, Europe, APAC, MEA, LATAM), And Segment Forecasts, 2019 - 2026
出版日: 2019年12月02日 ページ情報: 英文 130 Pages
概要

世界の美容医学市場規模は今後CAGR8.8%で拡大し、2026年までに168億米ドルに達すると予測されています。世界的高齢化が美容医学製品需要を高める主な要因となるとみられています。

当レポートでは、世界の美容医学市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入する企業のプロファイルについてまとめています。

第1章 調査方法と範囲

第2章 エグゼクティブサマリー

第3章 市場変動、動向、範囲

  • 市場見通し
  • 浸透および成長見通しマッピング
  • ユーザー見通し分析
  • 主なエンドユーザーリスト
  • 法規制の枠組み
  • 市場動向
  • 市場分析ツール

第4章 製品別市場

  • 定義と範囲
  • 市場シェア分析
  • セグメント概要
  • 製品別市場
  • 市場規模、予測、動向分析
    • エネルギーベースデバイス
    • インプラント
    • 皺防止製品

第5章 エンドユース別市場

  • 定義と範囲
  • 市場シェア分析
  • セグメント概要
  • エンドユース別市場
  • 市場規模、予測、動向分析
    • クリニック、ビューティーセンター
    • 在宅での使用

第6章 地域別市場分析

  • 定義と範囲
  • 市場シェア分析
  • 市場概要
  • 市場シェアと主要企業
  • SWOT分析
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場規模と予測、動向分析
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第7章 競合分析

  • 近年の発展と影響分析
  • 企業/競合分類
  • ベンダー環境
  • 公的企業主要
  • 民間企業
  • 主要企業プロファイル
図表

List of Tables

  • Table 1 Global Aesthetic Medicine Market, By Region, 2015 - 2026 (USD Million)
  • Table 2 Global Aesthetic Medicine Market, By Treatment Type, 2015 - 2026 (USD Million)
  • Table 3 North America Aesthetic Medicine Market, By Treatment Type, 2015 - 2026 (USD Million)
  • Table 4 U.S. Aesthetic Medicine Market, By Treatment Type, 2015 - 2026 (USD Million)
  • Table 5 Canada Aesthetic Medicine Market, By Treatment Type, 2015 - 2026 (USD Million)
  • Table 6 Europe Aesthetic Medicine Market, By Treatment Type, 2015 - 2026 (USD Million)
  • Table 7 U.K. Aesthetic Medicine Market, By Treatment Type, 2015 - 2026 (USD Million)
  • Table 8 Germany Aesthetic Medicine Market, By Treatment Type, 2015 - 2026 (USD Million)
  • Table 9 France Aesthetic Medicine Market, By Treatment Type, 2015 - 2026 (USD Million)
  • Table 10 Italy Aesthetic Medicine Market, By Treatment Type, 2015 - 2026 (USD Million)
  • Table 11 Spain Aesthetic Medicine Market, By Treatment Type, 2015 - 2026 (USD Million)
  • Table 12 Asia Pacific Aesthetic Medicine Market, By Treatment Type, 2015 - 2026 (USD Million)
  • Table 13 Japan Aesthetic Medicine Market, By Treatment Type, 2015 - 2026 (USD Million)
  • Table 14 China Aesthetic Medicine Market, By Treatment Type, 2015 - 2026 (USD Million)
  • Table 15 India Aesthetic Medicine Market, By Treatment Type, 2015 - 2026 (USD Million)
  • Table 16 Australia Aesthetic Medicine Market, By Treatment Type, 2015 - 2026 (USD Million)
  • Table 17 South Korea Aesthetic Medicine Market, By Treatment Type, 2015 - 2026 (USD Million)
  • Table 18 Latin America Aesthetic Medicine Market, By Treatment Type, 2015 - 2026 (USD Million)
  • Table 19 Brazil Aesthetic Medicine Market, By Treatment Type, 2015 - 2026 (USD Million)
  • Table 20 Mexico Aesthetic Medicine Market, By Treatment Type, 2015 - 2026 (USD Million)
  • Table 21 Argentina Aesthetic Medicine Market, By Treatment Type, 2015 - 2026 (USD Million)
  • Table 22 Middle East & Africa Aesthetic Medicine Market, By Treatment Type, 2015 - 2026 (USD Million)
  • Table 23 South Africa Aesthetic Medicine Market, By Treatment Type, 2015 - 2026 (USD Million)
  • Table 24 Saudi Arabia Aesthetic Medicine Market, By Treatment Type, 2015 - 2026 (USD Million)
  • Table 25 UAE Aesthetic Medicine Market, By Treatment Type, 2015 - 2026 (USD Million)
  • Table 26 List of Secondary sources
  • Table 27 List of emerging players

List of Figures

  • Figure 1 Market research process
  • Figure 2 Information procurement
  • Figure 3 Primary research pattern
  • Figure 4 Market research approaches
  • Figure 5 Value chain-based sizing & forecasting
  • Figure 6 QFD modelling for market share assessment
  • Figure 7 Market formulation & validation
  • Figure 8 Aesthetic medicine market segmentation
  • Figure 9 Market driver relevance analysis (Current & future impact)
  • Figure 10 Market restraint relevance analysis (Current & future impact)
  • Figure 11 Penetration & growth prospect mapping
  • Figure 12 SWOT analysis, by factor (political & legal, economic and technological)
  • Figure 13 Porter's five forces analysis
  • Figure 14 Aesthetic medicine market: procedure type movement analysis
  • Figure 15 Regional marketplace: Key takeaways
  • Figure 16 Regional outlook, 2018 & 2026
  • Figure 17 North America Aesthetic medicine market, 2015 - 2026 (USD Million)
  • Figure 18 U.S. Aesthetic medicine market, 2015 - 2026 (USD Million)
  • Figure 19 Canada Aesthetic medicine market, 2015 - 2026 (USD Million))
  • Figure 20 Europe Aesthetic medicine market, 2015 - 2026 (USD Million)
  • Figure 21 U.K. Aesthetic medicine market, 2015 - 2026 (USD Million)
  • Figure 22 Germany Aesthetic medicine market, 2015 - 2026 (USD Million)
  • Figure 23 Italy Aesthetic medicine market, 2015 - 2026 (USD Million)
  • Figure 24 Spain Aesthetic medicine market, 2015 - 2026 (USD Million)
  • Figure 25 France Aesthetic medicine market, 2015 - 2026 (USD Million)
  • Figure 26 Asia Pacific Aesthetic medicine market, 2015 - 2026 (USD Million)
  • Figure 27 Japan Aesthetic medicine market, 2015 - 2026 (USD Million)
  • Figure 28 China Aesthetic medicine market, 2015 - 2026 (USD Million)
  • Figure 29 India Aesthetic medicine market, 2015 - 2026 (USD Million)
  • Figure 30 Australia Aesthetic medicine market, 2015 - 2026 (USD Million)
  • Figure 31 South Korea Aesthetic medicine market, 2015 - 2026 (USD Million)
  • Figure 32 Latin America Aesthetic medicine market, 2015 - 2026 (USD Million)
  • Figure 33 Brazil Aesthetic medicine market, 2015 - 2026 (USD Million)
  • Figure 34 Mexico Aesthetic medicine market, 2015 - 2026 (USD Million)
  • Figure 35 Argentina Aesthetic medicine market, 2015 - 2026 (USD Million)
  • Figure 36 MEA Aesthetic medicine market, 2015 - 2026 (USD Million)
  • Figure 37 South Africa Aesthetic medicine market, 2015 - 2026 (USD Million)
  • Figure 38 Saudi Arabia Aesthetic medicine market, 2015 - 2026 (USD Million)
  • Figure 39 UAE Aesthetic medicine market, 2015 - 2026 (USD Million)
  • Figure 40 Strategy framework
目次
Product Code: 978-1-68038-733-9

The global aesthetic medicine market size is expected to reach USD 103.4 billion by 2026, exhibiting a CAGR of 8.9% during the forecast period, according to a new report by Grand View Research, Inc. Some key market drivers are rise in aging population, disposable income, and awareness about the efficacy of aesthetic treatments.

People aged between 25 and 65 years have prominent aging signs, such as wrinkles, fine lines, and dark spots. Rise in geriatric population is likely to boost the demand for aesthetic medicine due to significant rise in the number of target consumers. Moreover, the need for improved aesthetics in the working class population is likely to drive the demand over the forecast period. Improving employment rate, especially in the emerging markets, is anticipated to drive the demand for aesthetic medicine over the forecast period.

However, the presence of stringent regulatory framework to ensure product safety and efficacy is one of the primary factors limiting growth of the global aesthetic medicine market. Lack of skilled professionals required to perform surgical and minimally invasive procedures coupled with the growing overall treatment cost, is expected to hinder the market growth in the forthcoming years.

Further key findings from the report suggest:

  • Non-invasive procedures segment is expected to maintain its dominance throughout the forecast period. Growing preference for minimally or non-invasive cosmetic surgeries over invasive cosmetic surgeries attributed to various factors, such as lower costs, minimal trauma and incision, faster recovery, and low risk of complications is anticipated to fuel the segment growth
  • Botox injections, chemical peels, and soft tissue fillers are some of the most frequently performed non-invasive procedures to address some common issues, such as wrinkles, pigmentation, vascular conditions, loss of skin tone, and dull skin
  • Breast augmentation and nose reshaping in the invasive procedures segment are anticipated to witness rapid growth in the forthcoming years owing to availability of a rising number of advanced technologies and skilled surgeons
  • Asia Pacific is anticipated to witness rapid growth over the forecast period, owing to the presence of a large target population pool between 25 to 65 years in China and India and improving standards of living in the region
  • Some of the key players operating in the global market include Allergan, Inc.; Alma Laser; Cynosure; Galderma S.A.; Lumenis; Johnson and Johnson; Solta Medical, Inc.; and Syneron Medical Ltd.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market segmentation & scope
  • 1.2. Information procurement
    • 1.2.1. Purchased database
    • 1.2.2. GVR's internal database
    • 1.2.3. Secondary sources & third-party perspectives
    • 1.2.4. Primary research
  • 1.3. Information analysis
    • 1.3.1. Data analysis models
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Aesthetic Medicine Market Variables, Trends & Scope

  • 3.1. Market Lineage outlook
    • 3.1.1. Parent market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
      • 3.3.1.1. Increasing adoption of minimally invasive treatments
      • 3.3.1.2. Growing population aged between 25 and 65 years
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. Lack of reimbursement coverage
      • 3.3.2.2. Stringent regulatory framework
  • 3.4. Aesthetic Medicine: Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier Power
      • 3.4.1.2. Buyer Power
      • 3.4.1.3. Substitution Threat
      • 3.4.1.4. Threat from new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political Landscape
      • 3.4.2.2. Environmental Landscape
      • 3.4.2.3. Social Landscape
      • 3.4.2.4. Technology Landscape
      • 3.4.2.5. Legal Landscape
    • 3.4.3. Major Deals & Strategic Alliances Analysis

Chapter 4. Aesthetic Medicine Market: Segment Analysis, By Procedure Type, 2015 - 2026 (USD Million)

  • 4.1. Definitions & Scope
  • 4.2. Procedure type market share analysis, 2018 & 2026
  • 4.3. Global Aesthetic Medicine Market, By Procedure Type, 2015 to 2026
  • 4.4. Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the following
    • 4.4.1. Invasive procedures
      • 4.4.1.1. Breast augmentation
      • 4.4.1.2. Liposuction
      • 4.4.1.3. Nose reshaping
      • 4.4.1.4. Eyelid Surgery
      • 4.4.1.5. Tummy tuck
      • 4.4.1.6. Others
    • 4.4.2. Non-invasive procedure
      • 4.4.2.1. Botox injections
      • 4.4.2.2. Soft tissue fillers
      • 4.4.2.3. Chemical peel
      • 4.4.2.4. Laser hair removal
      • 4.4.2.5. Microdermabrasion
      • 4.4.2.6. Others

Chapter 5. Aesthetic Medicine Market: Regional Market Analysis, By Region, 2015 - 2026 (USD Million)

  • 5.1. Definitions & Scope
  • 5.2. Regional market share analysis, 2018 & 2026
  • 5.3. Regional Market Dashboard
  • 5.4. Regional Market: Key Players
  • 5.5. Market Size, & Forecasts, and Trend Analysis, 2019 to 2026:
  • 5.6. North America
    • 5.6.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
    • 5.6.2. Market estimates and forecast, by procedure type, 2015 - 2026 (USD Million)
    • 5.6.3. U.S.
      • 5.6.3.1. Market estimates and forecast, by procedure type, 2015 - 2026 (USD Million)
    • 5.6.4. Canada
      • 5.6.4.1. Market estimates and forecast, by procedure type, 2015 - 2026 (USD Million)
  • 5.7. Europe
    • 5.7.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
    • 5.7.2. Market estimates and forecast, by procedure type, 2015 - 2026 (USD Million)
    • 5.7.3. Germany
      • 5.7.3.1. Market estimates and forecast, by procedure type, 2015 - 2026 (USD Million)
    • 5.7.4. U.K.
      • 5.7.4.1. Market estimates and forecast, by procedure type, 2015 - 2026 (USD Million)
    • 5.7.5. France
      • 5.7.5.1. Market estimates and forecast, by procedure type, 2015 - 2026 (USD Million)
    • 5.7.6. Italy
      • 5.7.6.1. Market estimates and forecast, by procedure type, 2015 - 2026 (USD Million)
    • 5.7.7. Spain
      • 5.7.7.1. Market estimates and forecast, by procedure type, 2015 - 2026 (USD Million)
  • 5.8. Asia Pacific
    • 5.8.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
    • 5.8.2. Market estimates and forecast, by procedure type, 2015 - 2026 (USD Million)
    • 5.8.3. China
      • 5.8.3.1. Market estimates and forecast, by procedure type, 2015 - 2026 (USD Million)
    • 5.8.4. Japan
      • 5.8.4.1. Market estimates and forecast, by procedure type, 2015 - 2026 (USD Million)
    • 5.8.5. India
      • 5.8.5.1. Market estimates and forecast, by procedure type, 2015 - 2026 (USD Million)
    • 5.8.6. Australia
      • 5.8.6.1. Market estimates and forecast, by procedure type, 2015 - 2026 (USD Million)
    • 5.8.7. South Korea
      • 5.8.7.1. Market estimates and forecast, by procedure type, 2015 - 2026 (USD Million)
  • 5.9. Latin America
    • 5.9.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
    • 5.9.2. Market estimates and forecast, by procedure type, 2015 - 2026 (USD Million)
    • 5.9.3. Brazil
      • 5.9.3.1. Market estimates and forecast, by procedure type, 2015 - 2026 (USD Million)
    • 5.9.4. Mexico
      • 5.9.4.1. Market estimates and forecast, by procedure type, 2015 - 2026 (USD Million)
    • 5.9.5. Argentina
      • 5.9.5.1. Market estimates and forecast, by procedure type, 2015 - 2026 (USD Million)
  • 5.10. Middle East and Africa
    • 5.10.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
    • 5.10.2. Market estimates and forecast, by procedure type, 2015 - 2026 (USD Million)
    • 5.10.3. South Africa
      • 5.10.3.1. Market estimates and forecast, by procedure type, 2015 - 2026 (USD Million)
    • 5.10.4. Saudi Arabia
      • 5.10.4.1. Market estimates and forecast, by procedure type, 2015 - 2026 (USD Million)
    • 5.10.5. UAE
      • 5.10.5.1. Market estimates and forecast, by procedure type, 2015 - 2026 (USD Million)

Chapter 6. Aesthetic Medicine Market - Competitive Analysis

  • 6.1. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
  • 6.2. Vendor Landscape
    • 6.2.1. List of key distributors and channel partners
    • 6.2.2. Key company market share analysis, 2018
  • 6.3. Key companies profiled
    • 6.3.1. Cynosure (Hologic, Inc).
      • 6.3.1.1. Company Overview
      • 6.3.1.2. Financial Performance
      • 6.3.1.3. Product Benchmarking
      • 6.3.1.4. Strategic Initiatives
    • 6.3.2. Johnson & Johnson.
      • 6.3.2.1. Company Overview
      • 6.3.2.2. Financial Performance
      • 6.3.2.3. Product Benchmarking
      • 6.3.2.4. Strategic Initiatives
    • 6.3.3. Galderma S.A.
      • 6.3.3.1. Company Overview
      • 6.3.3.2. Financial Performance
      • 6.3.3.3. Product Benchmarking
      • 6.3.3.4. Strategic Initiatives
    • 6.3.4. Alma Lasers
      • 6.3.4.1. Company Overview
      • 6.3.4.2. Financial Performance
      • 6.3.4.3. Product Benchmarking
      • 6.3.4.4. Strategic Initiatives
    • 6.3.5. Allergan, Inc
      • 6.3.5.1. Company Overview
      • 6.3.5.2. Financial Performance
      • 6.3.5.3. Product Benchmarking
      • 6.3.5.4. Strategic Initiatives
    • 6.3.6. Solta Medical
      • 6.3.6.1. Company Overview
      • 6.3.6.2. Financial Performance
      • 6.3.6.3. Product Benchmarking
      • 6.3.6.4. Strategic Initiatives
    • 6.3.7. Lumenis
      • 6.3.7.1. Company Overview
      • 6.3.7.2. Financial Performance
      • 6.3.7.3. Product Benchmarking
      • 6.3.7.4. Strategic Initiatives
    • 6.3.8. Syneron Candela
      • 6.3.8.1. Company Overview
      • 6.3.8.2. Financial Performance
      • 6.3.8.3. Product Benchmarking
      • 6.3.8.4. Strategic Initiatives